ghk-cu inhibits 5-alpha reductase ✨ Peptide Spotlight: ✨ GHK-Cu is a powerful copper peptide known for its regenerative and anti-aging benefits. Naturally found in the body, this peptide plays an important role in skin repair Vibrant Hair & Skin with

Most available information comes from clinical trial protocols that don't translate easily to real-world use

7 Liu et al found that GQDs could also prevent A aggregation

Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research

MOTS-C research specifically noted that circulating levels decline with age, suggesting relevance increases with subject age